Oneview Healthcare (ONE) Q3 2025 TU earnings summary

Executive summary

• Cash balance at 30 September 2025 was €5.9m, down from €8.2m at 30 June 2025, mainly due to delayed customer renewal receipts.

• Net cash outflow for Q3 2025 was €2.2m, higher than the €1.2m outflow in Q3 2024, impacted by timing of a major customer payment.

• Commercial momentum continued with a new customer, Kennedy Krieger, and advanced contract discussions with several prospects.

Financial highlights

• Receipts from customers totaled €2.7m, a decrease of €1.0m year-over-year due to timing of receipts.

• Staff costs were €2.8m, 5% lower than prior year, reflecting benefits from June 2025 restructuring.

• Admin and corporate costs were €1.0m, slightly higher than prior year due to software fee inflation and timing.

• Payments to related parties totaled €171,000 for the quarter.

Outlook and guidance

• Strong U.S. pipeline with over 180 opportunities and expectations to secure additional new customer logos before year-end.

• On track to exceed 15,000 live endpoints by end of 2025, with 850 endpoints deployed in Q3.

• Focus remains on converting contracted endpoints to live, revenue-generating endpoints and sustaining commercial momentum into 2026.